# Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

> **NCT03110432** · — · COMPLETED · sponsor: **GWT-TUD GmbH** · enrollment: 1695 (actual)

## Conditions studied

- Dyslipoproteinemias
- Hypercholesterolemia, Familial
- Familial Hypercholesterolemia - Homozygous
- Familial Combined Hyperlipidemia

## Interventions

- **DRUG:** PCSK9 Inhibitor [EPC]
- **DRUG:** Standard lipid lowering therapy

## Key facts

- **NCT ID:** NCT03110432
- **Lead sponsor:** GWT-TUD GmbH
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-18
- **Primary completion:** 2024-04-17
- **Final completion:** 2024-04-17
- **Target enrollment:** 1695 (ACTUAL)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110432, "Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03110432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*